Linerixibat: Clinical Trials

3 trials of Linerixibat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 1, Completed 1, Not yet recruiting 1

Follow Linerixibat: new trials by email Literature Review of Linerixibat trials Research Report on Linerixibat

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
J-LINX: Japan LINerixibat eXtension Study
Linerixibat - Pruritus
Phase 3Not yet recruitingGlaxoSmithKline402026-10-092026-10-06
Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
Linerixibat, Placebo - Pruritus
Phase 3CompletedGlaxoSmithKline2382021-08-272026-07-22
Linerixibat Long-term Safety, and Tolerability Study
Linerixibat - Cholestasis
Phase 3Active not recruitingGlaxoSmithKline2422020-07-142026-06-22

Conditions studied

Liver Cirrhosis, Biliary (3)  ·  Cholestasis (2)  ·  Pruritus (2)

Sponsors

GlaxoSmithKline (3)

Countries

Germany (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Mexico (1)  ·  Poland (1)  ·  Russia (1)

Results publications

PMID 37953500

NIH funding

2019 (1)